BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/5/2017 11:10:00 AM | Browse: 1181 | Download: 2398
 |
Received |
|
2016-07-21 09:19 |
 |
Peer-Review Started |
|
2016-07-22 18:58 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2016-10-20 16:25 |
 |
Revised |
|
2016-11-02 02:18 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2016-11-11 16:44 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2016-11-28 18:03 |
 |
Articles in Press |
|
2016-11-28 18:03 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2016-12-15 15:12 |
 |
Publish the Manuscript Online |
|
2017-01-05 11:10 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Prospective Study |
| Article Title |
Trefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodies
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Piotr Eder, Kamila Stawczyk-Eder, Katarzyna Korybalska, Natasza Czepulis, Joanna Luczak, Liliana Lykowska-Szuber, Iwona Krela-Kazmierczak, Krzysztof Linke and Janusz Witowski |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Poznan University of Medical Sciences |
A helping hand (2014) |
|
| Corresponding Author |
Piotr Eder, MD, PhD, Department of Gastroenterology, Human Nutrition and Internal Diseases, Poznan University of Medical Sciences, Heliodor Swiecicki Hospital, Przybyszewskiego Street 49, 60-355 Poznan,
Poland. piotr.eder@op.pl
|
| Key Words |
Adalimumab; Crohn’s disease; Infliximab; Mucosal healing; Trefoil factors |
| Core Tip |
Mucosal healing (MH) is viewed as the holy grail of the efficacy of anti-tumor necrosis factor-α (anti-TNF-α) therapy for Crohn’s disease (CD), however performance of repeated colonoscopies is questionable for economical and safety reasons. We aimed to assess, whether serum trefoil factor-3 (TFF-3), a parameter engaged in maintaining mucosal integrity, could be useful in the assessment of MH. We found no correlation between TFF-3 and CD endoscopic activity and fecal calprotectin. Changes in TFF-3 did not reflect the degree to which MH was achieved. Thus, TFF-3 does not seem to be a reliable surrogate marker for MH in CD patients undergoing anti-TNF-α therapy.
|
| Publish Date |
2017-01-05 11:10 |
| Citation |
Eder P, Stawczyk-Eder K, Korybalska K, Czepulis N, Luczak J, Lykowska-Szuber L, Krela-Kazmierczak I, Linke K, Witowski J. Trefoil factor-3 is not a useful marker of mucosal healing in Crohn’s disease treated with anti-TNF-α antibodies. World J Gastroenterol 2017; 23(1): 135-140 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i1/135.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i1.135 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.